After analyzing the gene copy number and expression of SEC62 in tissue samples of NSCLC patients, we observed that lung cancer tissue shows a SEC62 amplification as well as SEC62 overexpression at both the mRNA and protein levels. This evidence concerns the gene SEC62 and non-small cell lung carcinoma.